Multi Makmur Lemindo Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Multi Makmur Lemindo Tbk. trades at Rp124 (market cap 424.84B, 39.61M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 27.5× Multi Makmur Lemindo Tbk.'s market cap, and Multi Makmur Lemindo Tbk. is more actively traded (39.61M versus 429.7K). Which is the better fit depends on your goals.
| PIPA | TSPC | |
|---|---|---|
Market Cap | 424.84B | 11.68T |
Volume | 39.61M | 429.7K |
Lot | 396.07K | 4.3K |
Turnover | 4.89B | 1.11B |
Average Price | 123.59 | 2,591.65 |
Value | 4.89B | 1.11B |
Indicative Equilibrium Price | 124 | 2,580 |
Indicative Equilibrium Volume | 2.9K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Multi Makmur Lemindo Tbk (the Company) was established based on Notarial Deed No. 66 dated January 11, 2012 of Deni Nugraha, S.E., S.H., M.Kn., notary in Tangerang. The Company started its commercial operations in 2005.
Read more on PIPA →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →